Log In
BCIQ
Print this Print this
 

TL-118

  Manage Alerts
Collapse Summary General Information
Company Tiltan Pharma Ltd.
DescriptionFixed dose combination of an NSAID, alkylating agent, H2 antagonist and sulfonamide
Molecular Target
Mechanism of ActionHistamine H2 receptor agonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today